Nateglinide
- 1 lab in 1 country
- Human trial1
Outcomes
1Insulin
upin humans1
1 study
Insulin
upin humans1
Nateglinide increases insulin in humans.
“Area under the curve (AUC) for insulin response was significantly increased in the nateglinide and control groups”
Human trialpostprandial in newly diagnosed type 2 diabetes270 mg/day12 weeks
Cardiovascular diabetology24 Mar 2010
Latest
Cardiovascular Diabetology
Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
Randomised trial in 30 peopleEndothelial dysfunction